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Developing B cells must assemble and express genes encod-
ing the immunoglobulin heavy (Igh) and light (Igl) chains of 
the B cell receptor (BCR; Rajewsky, 1996). This process oc-
curs through V(D)J recombination, a reaction that assembles 
the second exon of lymphocyte antigen receptor genes from 
component variable (V), joining (J), and, at some loci, diver-
sity (D) gene segments (Fugmann et al., 2000). V(D)J recom-
bination is initiated when the RAG endonuclease, composed 
of RAG-1 and RAG-2, introduces DNA double-strand 
breaks (DSBs) at a pair of recombining gene segments, gen-
erating two blunt signal DNA ends and two hairpin-sealed 
coding DNA ends (Fugmann et al., 2000). RAG DSBs are 
generated in G1 phase lymphocytes, where they activate the 
ataxia-telangiectasia mutated (ATM) DNA damage response 
(DDR) kinase (Desiderio et al., 1996; Helmink and Sleck-
man, 2012). In G1-phase cells, ATM inhibits S-phase entry by 
initiating canonical cell cycle checkpoint pathways through 
induction of p53 and directs DSB repair by nonhomologous 
end joining (NHEJ; Shiloh, 2003; Helmink and Sleckman, 
2012). In addition, in response to RAG DSBs, ATM activates 
a genetic program that may function to regulate processes 
required for normal lymphocyte development (Bredemeyer 
et al., 2008; Bednarski et al., 2012; Helmink and Sleckman, 
2012; Steinel et al., 2013).
B cell development requires the sequential assembly of 
Igh chain genes in pro–B cells and Igl chain genes (Igl κ [Igk] 
or Igl λ) in pre–B cells (Rajewsky, 1996). The ordered assem-
bly of immunoglobulin receptor genes is directed by signals 
from cell surface receptors. The IL-7r signals through AKT 
and JAK–STAT pathways to promote survival and to regulate 
Igh chain gene rearrangement in pro–B cells (Bertolino et al., 
2005; Clark et al., 2014). Productive assembly of an Igh chain 
gene leads to its expression with the surrogate light chain 
(λ5 and Vpre–B) and the CD79A–CD79B heterodimer (Igα 
and Igβ, respectively) to generate the pre–BCR (Herzog et 
al., 2009; Rickert, 2013). Oligomerization of the pre–BCR, 
through ligand-dependent or -independent mechanisms, ac-
tivates the SYK tyrosine kinase, leading to phosphorylation of 
the adaptor protein BLNK (also known as SLP-65; Herzog et 
al., 2009; Rickert, 2013).
Pre–BCR signals, along with those from the IL-7r, pro-
mote the developmental transition of pro–B cells to rapidly 
cycling, large pre–B cells (Herzog et al., 2009; Rickert, 2013; 
Clark et al., 2014). Pre–BCR and IL-7r signals synergize to 
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drive proliferation, whereas they independently regulate dif-
ferentiation and survival, respectively. Activation of STAT5 by 
the IL-7r inhibits Igk germline transcription and activation of 
AKT by the IL-7r inhibits Rag1 and Rag2 gene expression, 
both of which prevent Igk gene assembly (Amin and Schlissel, 
2008; Mandal et al., 2009, 2011; Corfe and Paige, 2012; Ochiai 
et al., 2012). Moreover, in cycling cells RAG-2 is degraded 
in S-phase (Desiderio et al., 1996). Thus, proliferative signals 
must be attenuated for large pre–B cells to transit to the small 
pre–B cell stage where Igk chain gene assembly is initiated 
(Rolink et al., 1991; Johnson et al., 2008; Ochiai et al., 2012; 
Clark et al., 2014). IL-7r signals are attenuated by the pre–
BCR, which inhibits AKT, a key molecule downstream of the 
IL-7r (Herzog et al., 2008; Ochiai et al., 2012). Additionally, 
pre–BCR signals induce CXCR4, which can affect the local-
ization of pre–B cells with respect to IL-7–producing stromal 
cells (Tokoyoda et al., 2004; Johnson et al., 2008). Moreover, 
activation of RAS by the pre–BCR in large pre–B cells pro-
motes exit from the cell cycle (Mandal et al., 2009). Loss of 
IL-7r signaling leads to increased SYK and BLNK expression, 
which reinforces pre–BCR signaling (Ochiai et al., 2012).
Pre–BCR signals are required to initiate Igk chain gene 
assembly through activation of transcription factors and his-
tone modifications that regulate Igk accessibility and RAG 
recruitment (Clark et al., 2014). The pre–BCR induces ex-
pression of IRF4, which, together with PU.1, binds the 3′ 
Igk enhancer to promote Igk germline transcription and 
rearrangement (Pongubala et al., 1992; Johnson et al., 2008; 
Clark et al., 2014). Small pre–B cells often undergo multiple 
sequential Igk rearrangements over several days as they at-
tempt to generate a functional Igk chain gene (Casellas et al., 
2001). Once RAG DSBs are generated, the pre–BCR must 
be prevented from initiating additional Igk rearrangements. 
Moreover, activation of SYK by the pre–BCR could drive 
small pre–B cells with RAG DSBs into cycle (Rolink et al., 
2000; Wossning et al., 2006; Herzog et al., 2009; Rickert, 
2013). In pre–B cells, RAG DSBs activate canonical cell cycle 
checkpoint pathways, including p53 (Guidos et al., 1996; 
Helmink and Sleckman, 2012). However, in other cell types 
these checkpoint pathways can be overridden by proliferative 
signals, such as those from cytokine receptors (Quelle et al., 
1998; Sitko et al., 2008). Thus, unopposed pre–BCR signaling 
could drive pre–B cells with RAG DSBs into cycle promot-
ing aberrant RAG DSB repair and genome instability.
We reasoned that pre–BCR signaling must be regulated 
to order Igk chain gene assembly and prevent these signals 
from driving pre–B cells with RAG DSBs into cycle. Indeed, 
we show here that RAG DSBs activate a cell type–specific 
checkpoint pathway that inhibits pre–BCR signaling. This 
checkpoint pathway suppresses SYK and BLNK expression, 
inactivating pre–BCR signals to both prevent cell cycle pro-
gression and regulate Igk chain gene assembly. We propose that 
pre–B cells toggle between pre–BCR signaling and this RAG 
DSB-dependent checkpoint pathway, allowing for iterative 
Igk chain gene assembly while maintaining genome stability.
RES ULTS
RAG DSB signals regulate the genetic 
program of small pre–B cells
To elucidate the pre–B cell genetic program regulated by 
RAG DSB signals, we used mice deficient in RAG-1 or the 
Artemis endonuclease that express the μIgh and Bcl2 trans-
genes (Rag1−/−:μIgh:Bcl2 and Art−/−:μIgh:Bcl2, respectively; 
Bednarski et al., 2012). The μIgh transgene enables formation 
of a pre–BCR, allowing for pre–B cell development in these 
mice, and the Bcl2 transgene supports pre–B cell survival in 
vitro (Bednarski et al., 2012). Culturing bone marrow from 
these mice in the presence of IL-7 leads to the selective ex-
pansion of large pre–B cells (Rolink et al., 1991; Johnson et 
al., 2008; Bednarski et al., 2012). Upon withdrawal of IL-7, 
these cells transit to the small pre–B cell stage and induce 
RAG expression (Bednarski et al., 2012; Steinel et al., 2013; 
Fig. S1). Rag1−/−:μIgh:Bcl2 small pre–B cells do not gener-
ate RAG DSBs. Art−/−:μIgh:Bcl2 small pre–B cells generate 
RAG DSBs at Igk, but these DSBs are not repaired because 
Artemis is required to open hairpin-sealed coding DNA ends 
(Helmink and Sleckman, 2012; Fig. 1 A). These DSBs activate 
DDR, as indicated by phosphorylation of p53 (Fig. 1 B).
Gene profiling revealed that ∼3,000 genes change in ex-
pression (>1.5-fold) in Art−/−:μIgh:Bcl2 or Rag1−/−:μIgh:Bcl2 
pre–B cells as they transition from large (in IL-7) to small 
(IL-7 withdrawal) pre–B cells (Fig.  1, C-E; and Table S1). 
Many of these gene expression changes are observed during 
B cell development in vivo (Heng and Painter, 2008; Fig. 1 F). 
Comparison of Art−/−:μIgh:Bcl2 and Rag1−/−:μIgh:Bcl2 
small pre–B cells reveals that RAG DSB signals regulate a 
significant fraction (∼40%) of the gene expression changes 
that occur during the transition of large to small pre–B cells 
(RAG DSB dependent; Fig. 1, C–E; and Table S1).
ATM and NIK activate NF-κB2 in small pre–B cells
In small pre–B cells, RAG DSBs induce expression of the 
Relb and Nfkb2 (p100) genes, which encode the principal 
components of the noncanonical NF-κB (NF-κB2) pathway 
(Hayden and Ghosh, 2012; Sun, 2012; Fig. 2 A and Table S1). 
This depends on the activation of ATM as revealed by anal-
yses of Art−/−:Atm−/−:μIgh:Bcl2 small pre–B cells in vitro 
and Atm−/− pre–B cells in vivo (Fig. 2, A and B). The p100 
and RELB proteins are induced by RAG DSBs (compare 
Art−/−:μIgh:Bcl2 and Rag1−/−:μIgh:Bcl2) in small pre–B cells 
that express ATM and have intact DDR signals (compare 
Art−/−:μIgh:Bcl2 and Art−/−:Atm−/−:μIgh:Bcl2; Fig.  2  C). 
Formation of the transcriptionally active p52-RELB het-
erodimer, which translocates to the nucleus, requires cleav-
age of p100 to form p52 (Hayden and Ghosh, 2012; Sun, 
2012). In this regard, the robust generation of p52 and the 
nuclear translocation of p52 and RELB are observed only 
in small pre–B cells with RAG DSBs (Fig. 2, C and D). In 
mature B cells, cleavage of p100 to form p52 depends on 
the NF-κB–inducing kinase (NIK; Hayden and Ghosh, 2012; 
Sun, 2012). Similarly, in small pre–B cells NIK is required 
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for the generation of p52, as Art−/−:Nik−/−:μIgh:Bcl2 small 
pre–B cells show induction of p100 in response to RAG 
DSBs, but inefficient conversion of p100 to p52 (Fig. 2 E). 
Thus, NF-κB2 is activated in small pre–B cells through the 
RAG DSB-dependent induction of p100 and RELB coupled 
with the NIK-dependent conversion of p100 to p52.
Figure 1. RAG DSBs regulate the genetic program in small pre–B cells. (A) Southern blot of SacI and EcoRI digested genomic DNA from 
Rag1−/−:μIgH:Bcl2, Art−/−:μIgH:Bcl2 and Art−/−:Atm−/−:μIgH:Bcl2 small pre–B cells in IL-7 (0 d) and after withdrawal of IL-7 (IL-7 wd) for the indi-
cated days. Bands reflecting the germline (GL) Igk locus and Jk coding ends (Jk1, Jk2, Jk4, and Jk5 CE) are indicated as are molecular weight markers 
in kilobases. (B) Western blot of phosphorylated p53 (p-p53) in pre–B cells in IL-7 (0 d) and after withdrawal of IL-7 (IL-7 wd) for the indicated 
days. GAP DH is shown as a protein loading control. Data in A and B are representative of at least three independent experiments. (C) Heat map 
of gene expression changes in Rag1−/−:μIgH:Bcl2 and Art−/−:μIgH:Bcl2 pre–B cells in the presence of IL-7 (+ IL-7) and 2 d after IL-7 withdrawal 
(− IL-7). Columns represent three independent cell cultures of each genotype. Representative genes are delineated to the right. (D and E) RT-PCR 
validation of representative RAG DSB-independent (D) or RAG DSB-dependent (E) gene expression changes from C. mRNA expression was assessed 
in Rag1−/−:μIgH:Bcl2 (black) and Art−/−:μIgH:Bcl2 (red) pre–B cells in the presence of IL-7 (+ IL-7) and 2 d after IL-7 withdrawal (− IL-7). Data are 
mean and standard error for three replicates. (F) Venn diagram comparing gene expression changes that occur during the transition of large to 
small pre–B cells in the bone marrow of WT mice (ImmGen; blue) and gene expression changes we observe in small pre–B cells after withdrawal of 
IL-7 (red). The ImmGen data represents all genes that were significantly changed (p-value < 0.05) between large and small pre–B cells. *, P ≤ 0.05; 
**, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 0.0001 by Student’s t test.
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NF-κB2 induces SPIC expression
Analysis of Art−/−:μIgh:Bcl2 and Art−/−:Nfkb2−/−:μIgh:Bcl2 
small pre–B cells revealed that ∼15% of the genes regulated 
by RAG DSBs depend on NF-κB2 (Fig. 3 A and Table S2). 
One of these genes encodes SPIC, an ETS family transcription 
factor with significant homology to PU.1 and SPIB (Bemark 
et al., 1999; Hashimoto et al., 1999). Induction of Spic in re-
sponse to RAG DSBs depends on ATM and NF-κB2, as indi-
cated by analysis of Art−/−:μIgh:Bcl2, Art−/−:Atm−/−:μIgh:Bcl2, 
and Art−/−:Nfkb2−/−:μIgh:Bcl2 small pre–B cells (Fig. 3 B). To 
assess SPIC expression in vivo, we used mice with a Spic re-
porter allele, Spicigfp, which contains an IRES-EGFP targeted 
to a 3′ noncoding exon of the Spic gene (Haldar et al., 2014). 
Approximately 40% of bone marrow small pre–B cells from 
Art−/−:Spicigfp/igfp:μIgh:Bcl2 mice express EGFP (Fig.  3  C). 
CD40 surface expression is induced by RAG DSB signals, 
and thus functions as a marker of small pre–B cells with RAG 
DSBs (Bredemeyer et al., 2008). All of the EGFP-positive 
small pre–B cells in Art−/−:Spicigfp/igfp:μIgh:Bcl2 mice also ex-
press CD40 (Fig. 3 C). In contrast, none of the small pre–B 
Figure 2. Signals from RAG DSBs activate NF-κB2. (A) Nfkb2 and Relb mRNA expression in Rag1−/−:μIgH:Bcl2 (black), Art−/−:μIgH:Bcl2 (red), and 
Art−/−:Atm−/−;μIgH:Bcl2 (blue) small pre–B cells 2 d after IL-7 withdrawal. Data are mean and standard error for three replicates. (B) Nfkb2 and Relb mRNA 
expression in sorted small pre–B cells from Rag1−/−:μIgH:Bcl2, WT, and Atm−/− mice. Data are mean and standard error from three independent mice of 
each genotype. (C) Western blot of NF-κB2 (p100 and p52) and RELB in pre–B cells in IL-7 (0 d) and after withdrawal of IL-7 (IL-7 wd) for the indicated 
days. GAP DH is shown as a protein loading control. (D) Western blot of NF-κB2 (p100 and p52) and RELB incytoplasmic andnuclear fractions from pre–B 
cells in IL-7 (0 d) and after withdrawal of IL-7 for the indicated days. LaminB and GAP DH are shown as protein loading controls for nuclear and cytoplasmic 
fractions, respectively. (E) Western blot of NF-κB2 (p100 and p52) in pre–B cells in IL-7 (0 d) and after withdrawal of IL-7 (IL-7 wd) for the indicated days. 
GAP DH is shown as a protein loading control. Data in all panels are representative of at least three independent experiments. *, P ≤ 0.05; **, P ≤ 0.01; 
***, P ≤ 0.005 by Student’s t test.
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cells from Rag1−/−:Spicigfp/igfp:μIgh:Bcl2 mice express EGFP 
or CD40 (Fig. 3 C). Together, these data are consistent with 
the interpretation that SPIC expression in small pre–B cells 
is induced by RAG DSBs through the sequential activa-
tion of ATM and NF-κB2.
RAG DSBs negatively regulate pre–BCR signaling
Ectopic SPIC expression in mature B cells inhibits BCR 
signaling, and in lymphocyte progenitors it blocks B cell 
development at the pre–B cell stage (Zhu et al., 2008). As 
RAG DSBs induce SPIC, we reasoned that they might neg-
atively regulate pre–BCR signaling. Indeed, we find that 
expression of both SYK and BLNK is reduced in small 
pre–B cells with RAG DSBs (Art−/−:μIgh:Bcl2) but not 
in those without RAG DSBs (Rag1−/−:μIgh:Bcl2) or in 
ATM-deficient (Art−/−:Atm−/−:μIgh:Bcl2) pre–B cells 
with RAG DSBs (Fig.  4, A–D). Consistent with the re-
duction in these proteins, small pre–B cells with RAG 
DSBs have decreased pre–BCR signaling as evidence by 
reduced levels of phosphorylated BLNK (Fig.  4  A). Ex-
pression of BTK, another pre–BCR signaling protein, is 
not affected by RAG DSBs but is minimally decreased by 
loss of IL-7r signals (Fig. 4, E and F). Retroviral expres-
sion of SPIC in Rag1−/−:μIgh:Bcl2 small pre–B cells leads 
to inhibition of both Blnk and Syk expression (Fig. 5 A). 
Moreover, SPIC-expressing (EGFP-positive) small pre–B 
cells in Spicigfp/igfp mice have lower levels of Syk and Blnk 
transcripts as compared with cells that do not express SPIC 
(EGFP negative; Fig. 5 B). We conclude that RAG DSBs 
antagonize the expression of two key pre–BCR signaling 
proteins, SYK and BLNK, through the sequential induction 
of ATM, NF-κB2, and SPIC.
SPIC antagonizes PU.1 binding at Syk and Blnk
The expression of Blnk depends on PU.1 binding to its 
promoter (Schweitzer and DeKoter, 2004; Xu et al., 2012). 
SPIC functions as a transcriptional repressor that recognizes 
the same DNA sequence as PU.1 but, unlike PU.1, SPIC is 
unable to bind IRF4, which is required to initiate transcrip-
tion (Bemark et al., 1999; Hashimoto et al., 1999; Carlsson et 
al., 2003). To determine whether SPIC induction by RAG 
DSBs affects PU.1 activity, we compared PU.1 binding at 
Blnk in Art−/−:μIgh:Bcl2 and Rag1−/−:μIgh:Bcl2 small pre–B 
cells. Although PU.1 levels are similar in these cells, bind-
ing of PU.1 to the Blnk promoter is markedly reduced in 
Art−/−:μIgh:Bcl2 small pre–B cells, which have RAG DSBs 
and up-regulate SPIC, as compared with Rag1−/−:μIgh:Bcl2 
small pre–B cells that do not express SPIC (Fig. 6, A and B). 
When SPIC is retrovirally expressed in Rag1−/−:μIgh:Bcl2 
small pre–B cells, we observe SPIC binding to both the Blnk 
promoter and a putative regulatory element upstream of the 
Syk gene (Zhang et al., 2012; Fig. 6, C and D). Moreover, we 
also observe decreased PU.1 binding at these regulatory ele-
ments in Rag1−/−:μIgh:Bcl2 small pre–B cells expressing SPIC 
(Fig. 6 E). Mutation of the conserved Ets domain (R175G) in 
SPIC (SPI CR175G) ablates SPIC binding to Blnk and Syk, sim-
ilar to previous findings for PU.1 (Pio et al., 1996; Suraweera 
et al., 2005; and unpublished data). Compared with SPIC, 
equivalent expression of SPI CR175G in Rag1−/−:μIgh:Bcl2 
small pre–B cells does not result in decreased PU.1 bind-
Figure 3. Signals from RAG DSBs induce SPIC expression. (A) Heat map of RAG DSB-dependent gene expression changes that require NF-κB2. 
Art−/−:μIgH:Bcl2 pre–B cells were compared with Rag1−/−:μIgH:Bcl2 pre–B cells to identify RAG DSB-dependent gene expression changes followed by 
comparison of Art−/−:μIgH:Bcl2 and Art−/−:Nfkb2−/−:μIgH:Bcl2 pre–B cells to identify NF-κB2–dependent changes. Columns represent three independent 
cell cultures of each genotype. Representative genes are delineated to the right. (B) Spic mRNA expression in Rag1−/−:μIgH:Bcl2 (black), Art−/−:μIgH:Bcl2 
(red), Art−/−:Atm−/−:μIgH:Bcl2 (blue), and Art−/−:Nfkb2−/−:μIgH:Bcl2 (green) small pre–B cells 2 d after IL-7 withdrawal. Data are mean and standard error 
for three replicates. (C) Flow cytometric analysis of CD40 (y-axis) and EGFP (x-axis) expression in bone marrow small pre–B cells (B220loCD43−IgM−) from 
Rag1−/−:Spicigfp/igfp:μIgH:Bcl2 and Art−/−:Spicigfp/igfp:μIgH:Bcl2 mice. Inset shows percent of cells in each quadrant. Data are representative of three indepen-
dent experiments. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005 by Student’s t test.
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ing at Blnk and Syk (Fig. 6, C and E). Together, these data 
suggest that, after induction by RAG DSBs, SPIC directly 
antagonizes PU.1 at cis-acting regulatory elements in both 
the Blnk and Syk loci.
SPIC inhibits germline transcription and RAG cleavage at Igk
SYK and BLNK signals from the pre–BCR induce IRF4 
to promote germline transcription and rearrangement of 
the Igk locus. Inhibition of pre–BCR signaling by RAG 
DSBs could feed back to suppress this process. Indeed, 
small pre–B cells with RAG DSBs (Art−/−:μIgh:Bcl2) 
exhibit decreased IRF4 expression and Igk germline 
transcripts as compared with Rag1−/−:μIgh:Bcl2 small 
pre–B cells (Fig.  7, A and B). Moreover, retroviral ex-
pression of SPIC in Rag1−/−:μIgh:Bcl2 small pre–B cells 
leads to a reduction in both Irf4 and germline Igk tran-
scripts (Fig.  7  C). Germline Igk transcription requires 
PU.1 binding at 3′ Igk enhancer, which is significantly 
reduced in Art−/−:μIgh:Bcl2 small pre–B cells with 
RAG DSBs as compared with Rag1−/−:μIgh:Bcl2 small 
pre–B cells (Fig. 7 D). Moreover, when SPIC is retrovi-
rally expressed in Rag1−/−:μIgh:Bcl2 small pre–B cells, 
Figure 4. RAG DSBs suppress pre–BCR sig-
naling. (A) Western blot of phosphorylated 
BLNK (p-BLNK) and total BLNK in pre–B cells 
in IL-7 (0 d) and following IL-7 withdrawal 
(IL-7 wd) for the indicated days. GAP DH is 
shown as a protein loading control. (B and C) 
Western blot of SYK in pre–B cells cultured 
in IL-7 (+) and 3 d after IL-7 withdrawal (–). 
GAP DH is shown as a protein loading control. 
(D and E) Blnk, Syk and Btk mRNA expression 
in Rag1−/−:μIgH:Bcl2 (black), Art−/−:μIgH:Bcl2 
(red), and Art−/−:Atm−/−;μIgH:Bcl2 (blue) small 
pre–B cells 3 d after IL-7 withdrawal. Data are 
mean and standard error for three replicates. 
(F) Western blot of BTK in pre–B cells cultured in 
IL-7 (+) and 3 d after IL-7 withdrawal (–). GAP 
DH is shown as a protein loading control. Data 
in A, B, C, and F are representative of at least 
three independent experiments. *, P ≤ 0.05; 
***, P ≤ 0.005; ****, P ≤ 0.0001 by Student’s t test.
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we observe SPIC binding at the 3′ Igk enhancer and a 
concomitant decrease in PU.1 binding (Fig. 7, E and F). 
Thus, SPIC negatively regulates germline Igk transcrip-
tion both by inhibiting pre–BCR signals that lead to 
IRF4 expression and by interfering with PU.1 binding 
at the 3′ Igk enhancer.
The activation of ATM by Igk rearrangements feeds back 
to inhibit the generation of additional RAG DSBs as indicated 
by increased RAG cleavage at Igk in Art−/−:Atm−/−:μIgh:Bcl2 
as compared with Art−/−:μIgh:Bcl2 small pre–B cells (Hewitt 
et al., 2009; Steinel et al., 2013; Fig. 1 A). Retroviral expres-
sion of SPIC in Art−/−:Atm−/−:μIgh:Bcl2 small pre–B cells 
results in decreased RAG cleavage at Igk (Fig.  7  G). This 
is indicated by the increase in Igk loci in the germline con-
figuration and a concomitant decrease in Igk coding ends 
in Art−/−:Atm−/−:μIgh:Bcl2 small pre–B cells expressing 
SPIC as compared with Art−/−:Atm−/−:μIgh:Bcl2 small pre–B 
cells expressing the empty retroviral vector (Fig. 7 G). We con-
clude that the ATM-dependent induction of SPIC by RAG DSBs 
in small pre–B cells feeds back to inhibit germline transcription 
and the generation of additional RAG DSBs at the Igk locus.
RAG DSBs inhibit pre–BCR–driven proliferation
SYK activation downstream of the pre–BCR can drive 
small pre–B cells into cycle in the absence of IL-7r signals 
(Rolink et al., 2000; Wossning et al., 2006). Indeed, we find 
that Rag1−/−:μIgh:Bcl2 small pre–B cells proliferate after 
IL-7 withdrawal, and this proliferation is blocked by the SYK 
kinase inhibitor BAY 61–3606 (unpublished data). Persistent 
pre–BCR signaling, and resulting SYK activation, could drive 
small pre–B cells with Igk RAG DSBs into cycle. Thus, inac-
tivation of pre–BCR signaling may be required in addition to 
canonical cell cycle checkpoint pathways (p53) to enforce G1 
arrest in small pre–B cells with RAG DSBs. In small pre–B 
cells, SYK activity is suppressed through sequential activa-
tion of NF-κB2 and SPIC by RAG DSBs (Fig. 4, B–D; and 
Fig.  5  A). Consistent with this, expression of NF-κB2 or 
SPIC in Rag1−/−:μIgh:Bcl2 small pre–B cells is sufficient to 
reduce cell cycle entry (Fig. 8, A and B).
Art−/−:μIgh:Bcl2 pre–B cells with RAG DSBs (CD40 
pos), which both suppress SYK expression and activate p53, 
are arrested in the G1-phase of the cell cycle as compared with 
cells without RAG DSBs (CD40 neg; Fig. 8 C). Surprisingly, 
loss of p53 (Art−/−:p53−/−:μIgh) leads to only a modest in-
crease in S-phase progression in cells with RAG DSBs (CD40 
pos), suggesting that inhibition of pre–BCR signaling may 
also enforce G1 arrest in these cells (Fig. 8 D). Indeed, ret-
roviral reconstitution of SYK significantly increases S-phase 
entry in Art−/−:p53−/−:μIgh small pre–B cells with RAG 
DSBs (CD40 pos; Fig. 8 E). Expression of SYK also increases 
S-phase entry in p53-sufficient Art−/−:μIgh:Bcl2 small pre–B 
cells with RAG DSBs (CD40 pos), but to a lesser extent than 
that observed in p53-deficient cells (Fig. 8, E and F). Thus, 
in pre–B cells, RAG DSBs must activate both the canonical 
checkpoint (p53) and a cell type–specific checkpoint pathway 
that inhibits pre–BCR signals to affect a complete G1 arrest.
DIS CUSSI ON
Here, we show that RAG DSBs activate a cell type–specific 
checkpoint pathway that functions to both enforce G1 cell 
cycle arrest and regulate Igk chain gene rearrangement in small 
pre–B cell. This occurs through the sequential activation of 
ATM and NF-κB2, which leads to induction of SPIC, a he-
matopoietic-specific transcriptional repressor. SPIC inhibits 
pre–BCR signaling by repressing the expression of SYK and 
BLNK. Additionally, SPIC directly antagonizes Igk locus germ-
line transcription and rearrangement. Thus, signals from RAG 
DSBs generated during Igk gene assembly are integrated into 
the signaling circuitry of developing pre–B cells.
In mature B cells, p100 and RELB are constitutively 
expressed and NF-κB2 activation occurs upon engagement 
of CD40 or BAFF receptors with their respective ligands, 
leading to stabilization of NIK and conversion of p100 to 
p52. In resting cells, NIK exists in a complex with the cIAP 
ubiquitin ligases, which mediate NIK degradation (Vallabha-
purapu et al., 2008; Zarnegar et al., 2008; Hayden and Ghosh, 
2012; Sun, 2012). Signals from the CD40 or BAFF receptors 
Figure 5. SPIC inhibits expression of Syk and Blnk. (A) Rag1−/−:μIgH:Bcl2 
small pre–B cells were transduced with an empty retrovirus or a retrovirus 
expressing SPIC. Blnk and Syk mRNA expression was assessed 2 d after 
IL-7 withdrawal. Data are mean and standard error for three replicates. 
(B) Blnk and Syk mRNA expression in EGFP-negative (–) and EGFP-express-
ing (+) small pre–B cells sorted from Spicigfp/igfp mice. Data are the mean 
and standard error from three independent mice. *, P ≤ 0.05; **, P ≤ 0.01; 
***, P ≤ 0.005 by Student’s t test.
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trigger dissociation of this complex and increased NIK levels 
(Vallabhapurapu et al., 2008; Zarnegar et al., 2008; Hayden 
and Ghosh, 2012; Sun, 2012). Similar to mature B cells, pre–B 
cells require NIK to promote the conversion of p100 to p52 
in response to RAG DSBs. However, in contrast to mature 
B cells, expression of p100 and RELB must be induced in 
pre–B cells, and this depends on the activation of ATM by 
RAG DSBs generated during Igl chain gene assembly. Thus, 
pre–B cells require the convergence of two signals (ATM and 
NIK) to activate NF-κB2.
In response to RAG DSBs, NF-κB2 induces the ex-
pression of SPIC, an ETS family transcription factor with ho-
mology to PU.1 and SPIB (Bemark et al., 1999; Hashimoto 
et al., 1999). PU.1 and SPIB are constitutively expressed in 
developing B cells, where they perform critical developmen-
tal functions (Schweitzer and DeKoter, 2004). In mature B 
cells, SPIC regulates BCR signaling and canonical NF-κB1 
activation (Zhu et al., 2008; Li et al., 2015). How SPIC is reg-
ulated and functions in early B cells has not been determined. 
Here, we show that in developing B cells, SPIC is induced by 
RAG DSBs. Consequently, SPIC is only expressed in small 
pre–B cells that are actively undergoing Igl chain gene rear-
rangement. SPIC represses transcription by interfering with 
PU.1 binding to critical cis-acting regulatory elements at the 
Igk locus and at the Blnk and Syk genes. In doing so, SPIC 
suppresses pre–BCR signaling, thereby enforcing a cell type–
specific checkpoint in pre–B cells in response to RAG DSBs.
In large pre–B cells, signals from the pre–BCR attenu-
ate IL-7r signals, which is required for transition to the small 
pre–B cell stage and for initiation of Igk chain gene assem-
bly (Rolink et al., 1991; Johnson et al., 2008; Mandal et al., 
2009; Ochiai et al., 2012; Clark et al., 2014). The pre–BCR 
Figure 6. SPIC displaces PU.1 from Syk and Blnk. (A) West-
ern blot of PU.1 in pre–B cells cultured in IL-7 (+) and 3 d after 
IL-7 withdrawal (–). GAP DH is shown as a protein loading con-
trol. (B) ChIP-qPCR of PU.1 binding at the Blnk promoter in 
Rag1−/−:μIgH:Bcl2 and Art−/−:μIgH:Bcl2 small pre–B cells 3 d 
after IL-7 withdrawal. (C–E) Rag1−/−:μIgH:Bcl2 small pre–B cells 
were transduced with an empty retrovirus, a retrovirus express-
ing SPIC, or a retrovirus expressing a DNA binding–deficient SPIC 
(SPI CR175G). (C) Western blot of FLAG was performed 2 d after 
IL-7 withdrawal. GAP DH is shown as a protein loading control. 
ChIP-qPCR of SPIC binding (D) and PU.1 binding (E) at the Blnk 
promoter and at a putative regulatory element located 10-kb up-
stream of the transcription start site for Syk was performed 2 d 
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signals through BLNK to antagonize AKT signaling down-
stream of the IL-7r (Herzog et al., 2008; Ochiai et al., 2012). 
Attenuation of IL-7r signaling leads to increased expression 
of SYK and BLNK, which further augments pre–BCR sig-
naling (Ochiai et al., 2012). We show that once Igk chain 
gene assembly has been initiated, RAG DSB signals feedback 
to inhibit the pre–BCR by suppressing the expression of 
SYK and BLNK, which could lead to reactivation of IL-7r 
signals. However, pre–BCR signals may also function to re-
position small pre–B cells to bone marrow niches devoid of 
Figure 7. SPIC inhibits Igl transcription and rearrangement. (A) Irf4 and germline Igk mRNA expression in Rag1−/−:μIgH:Bcl2 and Art−/−:μIgH:Bcl2 
small pre–B cells assessed 3 d after IL-7 withdrawal. Data are mean and standard error for three replicate experiments. (B) Western blot of IRF4 in pre–B 
cells in IL-7 (0 d) and after IL-7 withdrawal (IL-7 wd) for the indicated days. GAP DH is shown as a protein loading control. Data are representative of three 
independent experiments. (C) Rag1−/−:μIgH:Bcl2 small pre–B cells were transduced with an empty retrovirus or a retrovirus expressing SPIC. Irf4 and ger-
mline Igk mRNA expression were assessed 2 d after IL-7 withdrawal. Data are mean and standard error for three replicate experiments. (D) ChIP-qPCR of 
PU.1 binding at the 3′ Igk enhancer in Rag1−/−:μIgH:Bcl2 and Art−/−:μIgH:Bcl2 small pre–B cells 3 d after IL-7 withdrawal. (E and F) Rag1−/−:μIgH:Bcl2 small 
pre–B cells were transduced with an empty retrovirus or a retrovirus expressing SPIC. ChIP-qPCR of SPIC binding (E) and PU.1 binding (F) at the 3′ Igk en-
hancer was performed 2 d after IL-7 withdrawal. (G) Southern blot of SacI and EcoRI digested genomic DNA from Art−/−:Atm−/−:μIgH:Bcl2 small pre–B cells 
transduced with an empty retrovirus or a retrovirus expressing SPIC 3 d after IL-7 withdrawal. Bands reflecting the germline (GL) Igk locus and Jk coding 
ends (Jk1, Jk2, Jk4, and Jk5 CE) are indicated as are molecular weight markers in kilobases. Data in D–G are representative of two independent experiments. 
*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005 by Student’s t test.
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IL-7–producing stromal cells (Tokoyoda et al., 2004; John-
son et al., 2008). Moreover, in small pre–B cells, RAG DSBs 
induce CD69, SWAP-70, and l-selectin, which function in 
lymphocyte trafficking and localization (Bredemeyer et al., 
2008). This could enforce localization of pre–B cells in IL-7 
poor areas of the bone marrow once Igk chain assembly has 
initiated. RAG DSBs also induce the PIM2 kinase, which 
antagonizes IL-7r signals (Bednarski et al., 2012). Thus, 
although pre–BCR signaling is required for the ini-
tial suppression of IL-7r signaling in small pre–B cells, 
Figure 8. RAG DSBs inhibit pre–BCR-driven proliferation. (A and B) Rag1−/−:μIgH:Bcl2 small pre–B cells were transduced with an empty retrovirus 
or a retrovirus expressing NF-κB2 (A) or SPIC (B). Flow cytometric analysis of BrdU incorporation (y axis) and DNA content (7AAD; x axis) was performed 
after IL-7 withdrawal. Percentage of cells that entered S-phase during BrdU labeling (box) is indicated. Data are representative of at least three indepen-
dent experiments. (C) Cell cycle analysis was performed as in A on Art−/−:μIgH:Bcl2 small pre–B cells with RAG DSBs (CD40 pos) and those without RAG 
DSBs (CD40 neg) after IL-7 withdrawal. Percentage of cells that entered S-phase during BrdU labeling (box) is indicated. Data are representative of at least 
three independent experiments. (D) Cell cycle analysis of CD40 neg and CD40 pos Art−/−:μIgH:Bcl2 and Art−/−:p53−/−:μIgH small pre–B cells as in C. Graph 
represents the percentage of cells that entered S-phase. Data are mean and standard error for two independent experiments. (E and F) Art−/−:p53−/−:μIgH 
(E) and Art−/−:μIgH:Bcl2 (F) small pre–B cells were transduced with an empty retrovirus or a retrovirus expressing SYK. Cell cycle analysis of CD40 neg and 
CD40 pos pre–B cells was performed as in C. Graphs represent the percentage of cells that entered S-phase. Data in both panels are representative of three 
independent experiments. **, P ≤ 0.01; ****, P ≤ 0.0001 by Student’s t test.
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continued pre–BCR signaling may not be required to 
maintain this suppression.
Initiation of pre–BCR signaling occurs upon the acti-
vation of SYK, which phosphorylates BLNK (Herzog et al., 
2009; Rickert, 2013; Clark et al., 2014). We find that RAG 
DSBs inactivate pre–BCR signaling by inhibiting both SYK 
and BLNK. Why would it be important for RAG DSBs to 
inhibit both proteins? In the absence of SYK, ZAP-70 can 
phosphorylate BLNK, activating downstream signaling cas-
cades (Chen et al., 2005; Fallah-Arani et al., 2008). Thus, the 
isolated inhibition of SYK would not attenuate pre–BCR sig-
naling. BLNK antagonizes SYK activation by the pre–BCR 
(Flemming et al., 2003; Taguchi et al., 2004). Consequently, the 
isolated loss of BLNK increases SYK activation (Flemming et 
al., 2003; Taguchi et al., 2004). Indeed, both loss of BLNK 
and overactivation of SYK are associated with B cell transfor-
mation and leukemia (Flemming et al., 2003; Taguchi et al., 
2004; Perova et al., 2014; Geng et al., 2015). Thus, complete 
suppression of pre–BCR signaling by RAG DSBs would rely 
on the inactivation of both SYK and BLNK. Here, we have 
defined the signaling pathway that inhibits pre–BCR signal-
ing under physiological conditions in normal pre–B cells. 
Conceivably, this pathway could be therapeutically targeted 
in pre–B cell leukemias that depend on pre–BCR signaling.
DNA DSBs activate p53-dependent canonical check-
point pathways to prevent cell cycle progression until the 
DSBs have been repaired (Shiloh, 2003). However, in some 
cell types proliferative signals can bypass p53-mediated 
checkpoints, driving cells with DSBs through cell cycle and 
promoting genome instability (Quelle et al., 1998; Sitko et 
al., 2008). RAG DSBs activate p53 in G1-phase small pre–B 
cells (Guidos et al., 1996). However, we find that even in the 
absence of p53, small pre–B cells with RAG DSBs are still ar-
rested in G1. Furthermore, restoration of pre–BCR signaling 
through SYK expression overrides the p53-mediated check-
point leading to the S-phase progression of small pre–B cells 
with RAG DSBs. Thus, enforcement of the G1–S checkpoint 
in small pre–B cells depends on activation of both the ca-
nonical checkpoint (p53) and a cell type–specific check-
point pathway that inhibits pre–BCR proliferative signals. 
In the absence of ATM, these checkpoint pathways are de-
fective. Consequently, ATM-deficient pre–B cells with RAG 
DSBs enter cell cycle and persist in the periphery for several 
weeks (Callén et al., 2007).
Small pre–B cells undergo multiple rounds of Igl chain 
gene rearrangement over a span of several days as they at-
tempt to generate a productive Igl chain that can pair with 
the Igh chain to form a nonautoreactive BCR (Rajewsky, 
1996; Casellas et al., 2001). Pre–BCR signals initiate Igl chain 
rearrangement through induction of IRF4 and subsequent 
activation of germline Igk transcription (Johnson et al., 2008; 
Clark et al., 2014). Once RAG DSBs are generated in the 
Igk locus, additional RAG cleavage events must be inhibited. 
In this regard, we show that RAG DSBs suppress pre–BCR 
signaling, leading to a reduction in Igk germline transcrip-
tion and inhibition of additional DSBs at the Igk locus. This 
occurs through the ATM- and NF-κB2–dependent induc-
tion of SPIC, which inhibits SYK and BLNK and interferes 
with PU.1 binding to the Igk enhancer. This feedback circuit 
prevents pre–B cells with RAG DSBs from entering cycle 
and prevents additional RAG DSBs at the Igl locus until the 
initial rearrangement has been completed and ATM signaling 
is terminated. If this rearrangement encodes an Igk chain that 
forms a functional BCR, the cell transits to the immature B 
cell stage. However, if the Igk chain gene is not functional, 
loss of ATM signaling would lead to the reexpression of SYK 
and BLNK, leading to reactivation of pre–BCR signaling and 
induction of another Igk chain gene rearrangement. We pro-
pose that small pre–B cells toggle between pre–BCR signals 
and a RAG DSB-dependent cell-type specific checkpoint to 
order iterative Igl chain gene rearrangements and maintain 
genomic stability by preventing pre–B cells with RAG DSBs 
from entering cell cycle.
MAT ERIALS AND MET HODS
Mice. All mice were bred and maintained under specific 
pathogen–free conditions at the Washington University 
School of Medicine and were handled in accordance to the 
guidelines set forth by the Division of Comparative Medi-
cine of Washington University. Wild-type B6 mice (The 
Jackson Laboratory) were used as controls. p53−/− mice were 
purchased from The Jackson Laboratory. Spicigfp/igfp, Nik−/−, 
and Nfkb2−/− mice were generated as previously described 
(Yin et al., 2001; Zarnegar et al., 2004; Haldar et al., 2014). 
Spicigfp/igfp mice were on a B6 background. All other mice are 
on a mixed genetic background. In vivo studies were con-
ducted on 4–5-wk-old mice.
Cell culture. Primary pre–B cell cultures were generated from 
bone marrow harvested from 4–6-wk-old mice and cultured 
for 7–10 d at 2 × 106 cells/ml in media containing 5 ng/ml 
of IL-7 (Life Technologies). For IL-7 withdrawal experiments, 
cells were resuspended in media without IL-7 and main-
tained at 2 × 106 cells/ml.
Retroviral transduction and cDNA expression. pMSCV- 
mCherry-SYK was purchased from Addgene (plasmid 50045; 
Strijbis et al., 2013). cDNA encoding SPIC with a 5′Flag tag 
was cloned into the pOZ retrovirus containing an IRES se-
quence, followed by truncated human CD25 (hCD25) cDNA 
as a marker of transduced cells. A DNA binding–deficient 
SPIC was generated by mutating arginine 175 to glycine 
(R175G) using QuikChange II XL (Agilent) according to the 
manufacturer’s protocol (Pio et al., 1996; Suraweera et al., 
2005). Retrovirus was produced in platE cells by transfection of 
the retroviral plasmid with Lipofectamine 2000 (Life Technol-
ogies) according to the manufacturer’s protocol. Viral superna-
tant was collected and pooled from 24–72 h after transfection. 
Viral supernatant was used immediately to transduce cells or 
was concentrated before transduction. To concentrated viral 
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particles, PEG-8000 (Sigma-Aldrich; final concentration 8%) 
was added to viral supernatant, incubation at 4°C overnight, 
and centrifugation at 2,500 RPM for 20 min. Precipitated 
virus was resuspended at 300× concentration in sterile PBS. 
Pre–B cells were transduced with unconcentrated virus (40 × 
106 cells in 3 ml viral supernatant) or with concentrated virus 
(40 × 106 in 1 ml with 10× viral particles) in IL-7–containing 
media with polybrene (5 µg/ml; Sigma-Aldrich) by centrifuga-
tion for 2 h at 1,200 RPM at room temperature. 4 h later, fresh 
IL-7 media (2 mls) was added, and the cells were incubated 
overnight. Virus-containing media was removed and cells were 
cultured in fresh IL-7 media (2 × 106/ml). Cells expressing the 
retrovirus construct were identified by flow cytometric assess-
ment of hCD25 or mCherry expression using a FAC SCalibur 
(BD). Transduced cells were sorted using biotin-conjugated 
anti-hCD25 (BD) and anti-biotin magnetic beads (Miltenyi 
Biotec) on MS columns (Miltenyi Biotec) according to the 
manufacturer’s protocol.
Flow cytometric analyses and cell sorting. Flow cytometric 
analyses were performed on a FAC SCalibur or BD LSR-
Fortessa (BD). Sorting was conducted on a BD Aria (user- 
operated) or on a Sony Sy3200 through the Siteman Cancer 
Center Flow Cytometry Core Facility. FITC-conjugated 
anti-CD45R/B220 (clone RA3-6B2), phycoerythrin 
(PE)-conjugated anti-CD43 (clone S7), FITC-conjugated 
anti-CD43 (clone S7), PE-Cy7–conjugated anti-CD45/
B220 (clone RA3-6B2), allophycocyanin (APC)-conjugated 
anti-IgM (clone II/41), PE-conjugated anti-CD40 (clone 
1C10), and biotin-conjugated anti-CD40 (clone 3/23) were 
purchased from BD. APC-conjugated streptavidin was pur-
chased from eBioscience. PE-conjugated anti-hCD25 (clone 
BC96) and APC-conjugated anti-hCD25 (clone BC96) were 
purchased from BioLegend. APC-conjugated anti-mCherry 
(clone 16D7) was purchased from Life Technologies. Staining 
for intracellular proteins was performed using Cytofix/
Cytoperm solution (BD).
Cell cycle analysis. To assess pre–BCR driven proliferation, 
pre–B cells were resuspended in media without IL-7 and 
maintained at 2 × 106 cells/ml. 8 h after removal from IL-7, 
cells were pulsed BrdU for 2  h using the BrdU-FITC kit 
(BD) per the manufacturer’s instructions. DNA content was 
assessed by 7AAD (BD) or DAPI (Sigma-Aldrich). The SYK 
kinase inhibitor BAY 61–3606 (EMD Millipore) was used at 
10 µM and was added 24 h before IL-7 withdrawal.
Cell fractionation and Western blot. Cell fractionation was 
performed as previously described (Méndez and Stillman, 
2000). Western blots were done on whole-cell lysates as pre-
viously described (Bredemeyer et al., 2008). Anti–NF-κB2 
(recognizes p100 and p52; polyclonal), anti-RELB (clone 
C1E4), anti-BLNK (clone D8R3G), anti-SYK (clone 
D1I5Q), anti-BTK (clone D3H5), and anti-phospho(S15)-p53 
(polyclonal) antibodies were purchased from Cell Signaling 
Technology. Anti-TRAF2 (polyclonal), anti-TRAF3 (poly-
clonal), anti-IRF4 (clone E-7), anti-PU.1 (polyclonal), and 
anti-LaminB (clone G-1) were obtained from Santa Cruz 
Biotechnology. Anti-phosphorylated BLNK (clone J117-
1278) was purchased from BD. Anti-GAP DH (clone GAP 
DH-71.1) and anti-FLAG (clone M2) were from Sigma- 
Aldrich. Secondary reagents were horseradish peroxidase 
(HRP)–conjugated anti–mouse IgG (Cell Signaling Technol-
ogy) or anti–rabbit IgG (Cell Signaling Technology). Western 
blots were developed with ECL (Thermo Fisher Scientific) 
and ECL Prime (GE Healthcare).
Southern blot. Southern blot analyses of coding ends gener-
ated during rearrangement at the Igk locus were performed 
on genomic DNA digested with SacI and EcoRI using the 
JκIII probe and Tcrβ probe, as described previously 
(Bredemeyer et al., 2008).
RT-PCR. RNA was isolated using RNeasy (QIA GEN) and 
reversed transcribed using either a polyT primer or a random 
hexamer primer with SuperScriptII (Life Technologies) ac-
cording to the manufacturers’ protocol. RT-PCR was per-
formed using Brilliant II SYBR Green (Agilent) and acquired 
on an Mx3000P (Stratagene). Each reaction was run in tripli-
cate. Primer sequences are listed in Table S3.
Gene arrays. Three independent IL-7 cultures for each gen-
otype (Rag1−/−:μIgH:Bcl2, Art−/−:μIgH:Bcl2 and 
Art−/−:Nfkb2−/−:μIgH:Bcl2) were withdrawn from IL-7 
for 48  h. RNA was isolated using RNeasy (QIA GEN). 
Gene expression profiling was performed using Illumina 
MouseRef-8 expression microarrays by the Washington 
University Genome Technology Access Center according 
to the manufacturer’s protocols. Data have been deposited 
in NCBI’s Gene Expression Omnibus under accession no. 
GSE67854. Differentially expressed genes were identified 
by error-weighted analysis of variance (ANO VA; Partek 
Genomics Suite v6.12). Fold changes were calculated based 
on the mean of three cell lines for each genotype. Only 
those genes with a fold change of ≥1.5 and a p-value ≤ 
0.05 were considered for further analysis. ImmGen (Immu-
nological Genome project) project gene expression data 
were independently analyzed to identify all genes expres-
sion changes that were significantly changed (P < 0.05) be-
tween large and small pre–B cells (datasets: preB_FrC_BM 
vs. preB_FrD_BM; Heng and Painter, 2008).
Chromatin immunoprecipitation (ChIP). ChIP was performed 
using anti-PU.1 (Santa Cruz Biotechnology), anti-FLAG 
(Sigma-Aldrich), control rabbit IgG (Santa Cruz Biotechnol-
ogy), and control mouse IgG antibodies (eBioscience) as pre-
viously described (Ochiai et al., 2013). In brief, DNA from 
5 × 106 cells was cross-linked with 1% formaldehyde for 10 
min at room temperature Reaction was stopped with 125 µM 
Glycine. Cells were lysed with NP-40 and nuclei were frozen 
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in liquid nitrogen, and then lysed with SDS. DNA was soni-
cated with 30-s pulses for 60–90 cycles. DNA fragmentation 
was in the range of 0.5–1 kb and was monitored by agarose 
gel electrophoresis. Immunoprecipitation was performed 
with 1 µg of anti-PU.1 (polyclonal; Santa Cruz Biotechnol-
ogy) or control rabbit IgG (sc-2027) and protein A–Sepharose 
beads (Thermo Fisher Scientific). For FLAG ChIP, 2 µg of 
anti-FLAG (clone M2; Sigma-Aldrich) or control mouse IgG 
(clone P3.6.2.8.1; eBioscience) was first incubated with rab-
bit anti-mouse IgG (EMD Millipore) and immunoprecipita-
tion was performed with Protein A Dynabeads (Life 
Technologies). DNA was purified with QIAquick PCR pu-
rification kit (QIA GEN). Quantitative PCR was performed 
using Brilliant II SYBR Green (Agilent) and acquired on an 
Mx3000P (Stratagene). Primers are listed in Table S3.
Statistical analysis. For analyses other than gene array, 
p-values were generated via Student’s t test (unpaired, two-
tailed) using Prism (GraphPad Software).
Online supplemental material. Fig. S1 shows IL-7 culture 
system for studying RAG DSBs. Table S1 shows genes 
regulated by RAG DSBs. Table S2 shows genes regulated by 
NF-κB2. Table S3 shows sequences of primers. Online 
supplemental material is available at http ://www .jem .org /cgi 
/content /full /jem .20151048 /DC1.
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